BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986488 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986488\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06764771-2409@assetmemo.bio
DTSTAMP:20261121T005430Z
DTSTART;VALUE=DATE:20271015
DTEND;VALUE=DATE:20271016
SUMMARY:BMS-986488: Phase 1 readout est. (NCT06764771)
DESCRIPTION:BMS-986488\, phase 1.\nStudy: A Study of BMS-986488 as Monother
 apy and Combination Therapy in Participants With Advanced Malignant Tumors
 \nEstimated primary completion: 15 October 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/bms-986488#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT06764771
URL:https://assetmemo.bio/drug/bms-986488#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
